These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 220903)
21. Laboratory aids in the diagnosis of metabolic bone disease. Goldsmith RS Orthop Clin North Am; 1972 Nov; 3(3):545-60. PubMed ID: 4344932 [No Abstract] [Full Text] [Related]
23. Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy. Hoikka V; Savolainen K; Karjalainen P; Alhava EM; Sivenius J Ann Clin Res; 1982 Apr; 14(2):72-5. PubMed ID: 6983324 [TBL] [Abstract][Full Text] [Related]
24. [4 cases of osteomalacia during anticonvulsant or sedative treatment]. Alcalay M; Amor B; Bontoux D; Cayla J; Charbonnier A; Mery C; Rondier J; Miravet L Sem Hop; 1975 Dec; 51(49):3019-27. PubMed ID: 174222 [TBL] [Abstract][Full Text] [Related]
25. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone. Fujita T; Nomura M; Okajima S; Furuya H J Clin Endocrinol Metab; 1980 May; 50(5):927-31. PubMed ID: 6246136 [TBL] [Abstract][Full Text] [Related]
26. The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia. Mosekilde L; Christensen MS; Lund B; Sorensen OH; Melsen F Acta Endocrinol (Copenh); 1977 Mar; 84(3):559-65. PubMed ID: 576530 [TBL] [Abstract][Full Text] [Related]
27. Calcium and vitamin D metabolism in Guamanian Chamorros with amyotrophic lateral sclerosis and parkinsonism-dementia. Yanagihara R; Garruto RM; Gajdusek DC; Tomita A; Uchikawa T; Konagaya Y; Chen KM; Sobue I; Plato CC; Gibbs CJ Ann Neurol; 1984 Jan; 15(1):42-8. PubMed ID: 6546847 [TBL] [Abstract][Full Text] [Related]
28. Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets. Kruse K J Pediatr; 1995 May; 126(5 Pt 1):736-41. PubMed ID: 7751997 [TBL] [Abstract][Full Text] [Related]
29. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism. Drezner MK; Neelon FA; Haussler M; McPherson HT; Lebovitz HE J Clin Endocrinol Metab; 1976 Apr; 42(4):621-8. PubMed ID: 1083395 [TBL] [Abstract][Full Text] [Related]
30. Mineral and bone metabolism in thyroid disease: a review. Auwerx J; Bouillon R Q J Med; 1986 Aug; 60(232):737-52. PubMed ID: 3774957 [TBL] [Abstract][Full Text] [Related]
32. Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone. Drezner MK; Feinglos MN J Clin Invest; 1977 Nov; 60(5):1046-53. PubMed ID: 908749 [TBL] [Abstract][Full Text] [Related]
33. Metabolic effects of diphosphonate in primary hyperparathyroidism. Kaplan RA; Geho WB; Poindexter C; Haussler M; Dietz GW; Pak CY J Clin Pharmacol; 1977 Jul; 17(7):410-9. PubMed ID: 195983 [TBL] [Abstract][Full Text] [Related]
34. Different actions of vitamin D2 and D3 on bone metabolism in patients treated with phenobarbitone/phenytoin. Tjellesen L; Gotfredsen A; Christiansen C Calcif Tissue Int; 1985 May; 37(3):218-22. PubMed ID: 2990641 [TBL] [Abstract][Full Text] [Related]
35. Effect of age on variables relating to calcium and phosphorus metabolism in women. Kotowicz MA; Melton LJ; Cedel SL; O'Fallon WM; Riggs BL J Bone Miner Res; 1990 Apr; 5(4):345-52. PubMed ID: 2343774 [TBL] [Abstract][Full Text] [Related]
36. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol. Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407 [TBL] [Abstract][Full Text] [Related]
37. Accelerated bone resorption in senescence-accelerated mouse (SAM-P/6). Kawase M; Tsuda M; Matsuo T J Bone Miner Res; 1989 Jun; 4(3):359-64. PubMed ID: 2548375 [TBL] [Abstract][Full Text] [Related]
38. Resistance to vitamin D and parathyroid hormone. Moses AM N Engl J Med; 1978 Aug; 299(8):423-4. PubMed ID: 209328 [No Abstract] [Full Text] [Related]